Location: Home
  • search
  • go
  • Relate News
  • 1/7/2024Drug R&D and Product Registration News Digest January 2024 (1)
  • 1/6/2024Roche and MediLink Therapeutics Enter Global Deal to Develop Next-gen ...
  • 1/6/2024AstraZeneca and Allorion Strike Global Deal for Novel Preclinical-Stag...
  • 1/6/2024Boehringer Ingelheim partners with Ribo to develop new treatments for ...
  • 1/6/2024Avenzo Thera Announces Global License of CDK2 Inhibitor from Allorion ...
  • 1/6/2024Novartis Acquires Renal Disease Firm SanReno Therapeutics
  • 1/6/2024Menarini Group and Insilico Medicine Enter Global Deal for Novel KAT6 ...
  • 1/6/2024IASO BIO Announces New Partnership with Umoja Biopharma to Develop Ex...
  • 1/6/2024Bayer and RTW Make Equity Investment in Ji Xing Pharma
  • 1/6/2024Balancing Medical Innovation and Affordability in The New Healthcare E...
  • 12/29/2023Recent Official and Executive Moves
  • 12/29/2023Drug R&D and Product Registration News Digest December 2023 (4)
  • 12/29/2023Financial-related Company News Digest (December 2023)
  • 12/29/2023China Issues the Implementation Plan for Saving Drug Resources and Cur...
  • 12/28/2023Astellas and Elpiscience Enter Research and License Deal for Novel Bis...
  • 12/28/2023CDE Issues the Technical Guidelines for Clinically Relevant Communicat...
  • 12/28/2023China's Revised Measures for the Administration and Registration of Fo...
  • 12/27/2023Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win (Se...
  • 12/27/2023vTv Therapeutics Received Notice from Huadong Pharma for Termination o...
  • 12/27/2023Innovent and Xuanzhu Enter into Clinical Trial Collaboration for Combo...
  • 12/26/2023NMPA Solicits Comments on the Draft of GMP's Blood Product Appendix
  • 12/26/2023NHC Issues the 3rd Batch of Its Catalogue of Encouraged Generic Drugs
  • 12/26/2023AstraZeneca to Buy Gracell to Further Cell Therapy Ambition Across Onc...
  • 12/26/2023NMPA Issues the List of Reference Formulations for GQCE Studies (74th ...
  • 12/26/2023LianBio Licenses Its Rights for NBTXR3 in China and Other Asian Marke...
  • 12/26/2023China Issues Guidance Policy for High-Quality Development of Disease...
  • 12/26/20232024 Forecast: Big Pharma Reworks China Strategy, And Job Cuts Are Par...
  • 12/25/2023NHC Claims Occupational Health Improvements
  • 12/25/2023Mitsubishi Tanabe Sells Majority Stake of Chinese JV to Local Partner ...
  • 12/25/2023NMPA Solicits Comments on the Implementation Doc for Provisions for QC...
  • Page:22/718 Total number of articles:21536: [First][<<] [20] [21] [22] [23] [24] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group